Optic neuritis in Hong Kong: a 1-year follow-up study

被引:7
作者
Lau, Patrick P. K. [1 ]
Yau, Gordon S. K. [2 ]
Lee, Jacky W. Y. [2 ]
Wong, Winnie W. Y. [1 ]
Tam, Victor T. Y. [2 ]
Chan, Eric Y. T. [3 ]
Tse, Doris M. W. [1 ]
Yuen, Can Y. F. [2 ]
机构
[1] Caritas Med Ctr, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China
[2] Hong Kong Special Adm Reg, Caritas Med Ctr, Dept Ophthalmol, Kowloon, Hong Kong, Peoples R China
[3] Queen Mary Hosp, Dept Immunol, Hong Kong, Hong Kong, Peoples R China
关键词
NEUROMYELITIS-OPTICA; COHERENCE TOMOGRAPHY; MULTIPLE-SCLEROSIS; SPECTRUM; AQUAPORIN-4; ANTIBODIES;
D O I
10.1007/s10792-014-9945-5
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
To investigate the etiology and prevalence of optic neuritis in a Chinese population. This was a single centre prospective cohort study. Consecutive patients with either a first or recurrent attack of optic neuritis from November 2010 to December 2011 were recruited from a district hospital in Hong Kong Special Administrative Region, China. All patients underwent serology testing for NMO (neuromyelitis optica) IgG; oligoclonal bands from lumbar puncture; computer tomography and contrast magnetic resonance imaging (MRI) of the brain and orbit as well as visual field; and optical coherence tomography testing. Patients were followed up for 1 year after the initial attack. 30 optic neuritis subjects were recruited. 73.3 % (22/30) remain as clinical isolated syndrome (CIS) after 1-year follow-up. 10 % (3/30) patients developed multiple sclerosis. 10 % (3/30) were diagnosed with NMO and 6.7 % (2/30) with NMO-spectrum disorder. The majority of acute unilateral optic neuritis in Chinese was CIS in origin although a fraction does progress to develop MS or NMO-related disorders. Clinicians should be aware of the associations and offer appropriate systemic workups.
引用
收藏
页码:303 / 310
页数:8
相关论文
共 30 条
[1]   A population-based study of neuromyelitis optica in Caucasians [J].
Asgari, N. ;
Lillevang, S. T. ;
Skejoe, H. P. B. ;
Falah, M. ;
Stenager, E. ;
Kyvik, K. O. .
NEUROLOGY, 2011, 76 (18) :1589-1595
[2]   A RANDOMIZED, CONTROLLED TRIAL OF CORTICOSTEROIDS IN THE TREATMENT OF ACUTE OPTIC NEURITIS [J].
BECK, RW ;
CLEARY, PA ;
ANDERSON, MM ;
KELTNER, JL ;
SHULTS, WT ;
KAUFMAN, DI ;
BUCKLEY, EG ;
CORBETT, JJ ;
KUPERSMITH, MJ ;
MILLER, NR ;
SAVINO, PJ ;
GUY, JR ;
TROBE, JD ;
MCCRARY, JA ;
SMITH, CH ;
CHROUSOS, GA ;
THOMPSON, HS ;
KATZ, BJ ;
BRODSKY, MC ;
GOODWIN, JA ;
ATWELL, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (09) :581-588
[3]  
Blanco Y, 2010, NEUROLOGIA, V25, P5
[4]  
Brodsky M, 1997, NEUROLOGY, V49, P1404
[5]  
Brodsky M, 2008, ARCH NEUROL-CHICAGO, V65, P727, DOI 10.1001/archneur.65.6.727
[6]   Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis [J].
Clerico, M. ;
Faggiano, F. ;
Palace, J. ;
Rice, G. ;
Tintore, M. ;
Durelli, L. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02)
[7]   The predictive value of CSF oligoclonal banding for MS 5 years after optic neuritis [J].
Cole, SR ;
Beck, RW ;
Moke, PS ;
Kaufman, DI ;
Tourtellotte, WW .
NEUROLOGY, 1998, 51 (03) :885-887
[8]   Azathioprine Tolerability, efficacy, and predictors of benefit in neuromyelitis optica [J].
Costanzi, C. ;
Matiello, M. ;
Lucchinetti, C. F. ;
Weinshenker, B. G. ;
Pittock, S. J. ;
Mandrekar, J. ;
Thapa, P. ;
McKeon, A. .
NEUROLOGY, 2011, 77 (07) :659-666
[9]   Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis [J].
Ebers, GC ;
Rice, G ;
Lesaux, J ;
Paty, D ;
Oger, J ;
Li, DKB ;
Beall, S ;
Devonshire, V ;
Hashimoto, S ;
Hooge, J ;
Kastrukoff, L ;
Krieger, C ;
Mezei, M ;
Seland, P ;
Vorobeychi, G ;
Morrison, W ;
Nelson, J ;
Freedman, MS ;
Chrisie, S ;
Nelson, R ;
Rabinovitch, H ;
Freedman, C ;
Hartung, HP ;
Rieckmann, P ;
Archelos, J ;
Jung, S ;
Weilbach, F ;
Flachenecke, P ;
Sauer, J ;
Hommes, O ;
Jongen, P ;
Brouwer, S ;
McLeod, J ;
Pollard, J ;
Ng, R ;
Sandberg-Wollheim, M ;
Källén, K ;
Nilsson, P ;
Ekberg, R ;
Lundgren, A ;
Jadbäck, G ;
Wikström, J ;
Multanen, J ;
Valjakka, M ;
Carton, H ;
Lissoir, F ;
Declerq, I ;
Vieren, M ;
Peeters, E ;
Dubois, B .
LANCET, 1998, 352 (9139) :1498-1504
[10]   Should Most Patients With Optic Neuritis be Tested for Neuromyelitis Optica Antibodies and Should This Affect Their Treatment? [J].
Galetta, Steven L. ;
Cornblath, Wayne T. .
JOURNAL OF NEURO-OPHTHALMOLOGY, 2010, 30 (04) :376-379